£5,347
+267250%vs Feb 2024Active03060513Private limited companyWarwick
BIOTECH DESIGN AND VALIDATION LTD.
Significant control: Doctor Philip David Aidan James (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Biotech Design And Validation Ltd. sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BIOTECH DESIGN AND VALIDATION LTD. is an active private limited company (company number 03060513) incorporated on 24 May 1995, registered in Warwick. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 28 February 2025, showing net assets of £5,347 and cash of £9,362, with 2 employees on average. Net assets rose 267250% on the prior period (£2).
Peer position · net assets
By net assets it sits in the upper half of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Doctor Philip David Aidan James
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 24 May 199531 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 7 June 2027in 226 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£9,362
Not reported the period beforeNot reported
2
Not reported the period before| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £5,347 | £9,362 | — | £5,531 | — | — | 2 |
| 29 February 2024 | £2 | — | £2 | — | — | — | — |
Current ratio1.69Current assets ÷ creditors within one year
Cash per employee£4,681Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £5,347 at 28 February 2025
- Net assets up 10% or more on the prior period+267250.0% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.69
- Incorporated five or more years agoIncorporated 24 May 1995
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 226 days
- Next accounts duein 35 days
- Accounts period endNet assets £5,347 · small accounts
- Accounts period endNet assets £2 · small accounts
- Incorporated
08
Similar companies in Coventry
- ALLIANCE MEDICAL RADIOPHARMACY LIMITEDWarwick · inc. Oct 2002
- ECTOMEDICA LIMITEDCoventry · inc. Jan 2012
- AFZAL PHARMA LTDCoventry · inc. Jun 2014
- KARIMI PHARMA LTDCoventry · inc. Feb 2022
- KOVIMAN BIOTECHNOLOGY LIMITEDWest Midlands, England · inc. Jul 2026
All companies incorporated on 24 May 1995 · in May 1995.
09
Reminders for BIOTECH DESIGN AND VALIDATION LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.